Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions

References

• Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294:1866-70; PMID:11729302; http://dx.doi.org/10.1126/science.294.5548.1866
   PubMed Web of Science ®Google Scholar
• Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994; 372:635-41; PMID:7990953; http://dx.doi.org/10.1038/372635a0
   PubMed Web of Science ®Google Scholar
• Schwabe JW, Neuhaus D, Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 1990; 348:458-61; PMID:2247153; http://dx.doi.org/10.1038/348458a0
   PubMed Web of Science ®Google Scholar
• McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci U S A 1996; 93:10069-73; PMID:8816752; http://dx.doi.org/10.1073/pnas.93.19.10069
   PubMed Web of Science ®Google Scholar
• Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 1998; 273:12101-8; PMID:9575154; http://dx.doi.org/10.1074/jbc.273.20.12101
   PubMed Web of Science ®Google Scholar
• Cowley SM, Parker MG. A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol 1999; 69:165-75; PMID:10418990; http://dx.doi.org/10.1016/S0960-0760(99)00055-2
   PubMed Web of Science ®Google Scholar
• McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 1995; 9:659-69; PMID:8592512
   PubMed Web of Science ®Google Scholar
• Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 1998; 54:105-12; PMID:9658195
   PubMed Web of Science ®Google Scholar
• Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A 1998; 95:2920-5; PMID:9501191; http://dx.doi.org/10.1073/pnas.95.6.2920
   PubMed Web of Science ®Google Scholar
• Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol Cell Biol 1999; 19:5363-72; PMID:10409727; http://dx.doi.org/10.1128/MCB.19.8.5363
   PubMed Web of Science ®Google Scholar
• Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392:49-53; PMID:8769313; http://dx.doi.org/10.1016/0014-5793(96)00782-X
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93:5925-30; PMID:8650195; http://dx.doi.org/10.1073/pnas.93.12.5925
   PubMed Web of Science ®Google Scholar
• Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Commun 1998; 243:122-6; PMID:9473491; http://dx.doi.org/10.1006/bbrc.1997.7893
   PubMed Web of Science ®Google Scholar
• Zhang WS, Andersson, G, Cheng, ER, Simpson, M, Warner and Gustafsson J.-Å. Update on estrogen signaling. FEBS Letters 2003; 546:17-24; PMID:12829231
   PubMed Web of Science ®Google Scholar
• Danielian PS, White R, Lees JA, Parker MG. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992; 11:1025-33; PMID:1372244
   PubMed Web of Science ®Google Scholar
• Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 1998; 12:3343-56; PMID:9808622; http://dx.doi.org/10.1101/gad.12.21.3343
   PubMed Web of Science ®Google Scholar
• Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996; 15:1292-300; PMID:8635462
   PubMed Web of Science ®Google Scholar
• Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000; 19:5406-17; PMID:11032808; http://dx.doi.org/10.1093/emboj/19.20.5406
   PubMed Web of Science ®Google Scholar
• Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001; 81:1535-65; PMID:11581496
   PubMed Web of Science ®Google Scholar
• Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270:1354-7; PMID:7481822; http://dx.doi.org/10.1126/science.270.5240.1354
   PubMed Web of Science ®Google Scholar
• Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR. Regulation of transcription by a protein methyltransferase. Science 1999; 284:2174-7; PMID:10381882; http://dx.doi.org/10.1126/science.284.5423.2174
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. J Biol Chem 2000; 275:15645-51; PMID:10747867; http://dx.doi.org/10.1074/jbc.M000042200
   PubMed Web of Science ®Google Scholar
• Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A 1996; 93:11540-5; PMID:8876171; http://dx.doi.org/10.1073/pnas.93.21.11540
   PubMed Web of Science ®Google Scholar
• Kraus WL, Kadonaga JT. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 1998; 12:331-42; PMID:9450928; http://dx.doi.org/10.1101/gad.12.3.331
   PubMed Web of Science ®Google Scholar
• Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002; 295:2465-8; PMID:11923541; http://dx.doi.org/10.1126/science.1068537
   PubMed Web of Science ®Google Scholar
• Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000; 275:39855-9; PMID:11053406; http://dx.doi.org/10.1074/jbc.C000567200
   PubMed Web of Science ®Google Scholar
• Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J Biol Chem 2000; 275:35848-56; PMID:10960470; http://dx.doi.org/10.1074/jbc.M001327200
   PubMed Web of Science ®Google Scholar
• Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R, Mandal M, Vadlamudi RK, Kumar R. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 2001; 3:30-7; PMID:11146623; http://dx.doi.org/10.1038/35050532
   PubMed Web of Science ®Google Scholar
• Norris JD, Fan D, Sherk A, McDonnell DP. A negative coregulator for the human ER. Mol Endocrinol 2002; 16:459-68; PMID:11875103; http://dx.doi.org/10.1210/mend.16.3.0787
   PubMed Web of Science ®Google Scholar
• Georgescu SP, Li JH, Lu Q, Karas RH, Brown M, Mendelsohn ME. Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha. Mol Endocrinol 2005; 19:2491-501; PMID:15941852; http://dx.doi.org/10.1210/me.2004-0311
   PubMed Web of Science ®Google Scholar
• Laherty CD, Billin AN, Lavinsky RM, Yochum GS, Bush AC, Sun JM, Mullen TM, Davie JR, Rose DW, Glass CK, et al. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell 1998; 2:33-42; PMID:9702189; http://dx.doi.org/10.1016/S1097-2765(00)80111-2
   PubMed Web of Science ®Google Scholar
• Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M, Evans RM. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev 2001; 15:1140-51; PMID:11331609; http://dx.doi.org/10.1101/gad.871201
   PubMed Web of Science ®Google Scholar
• Vo N, Fjeld C, Goodman RH. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol Cell Biol 2001; 21:6181-8; PMID:11509661; http://dx.doi.org/10.1128/MCB.21.18.6181-6188.2001
   PubMed Web of Science ®Google Scholar
• McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science 2002; 296:1642-4; PMID:12040178; http://dx.doi.org/10.1126/science.1071884
   PubMed Web of Science ®Google Scholar
• Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276:36869-72; PMID:11459850; http://dx.doi.org/10.1074/jbc.R100029200
   PubMed Web of Science ®Google Scholar
• Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997; 11:1486-96; PMID:9280064
   PubMed Web of Science ®Google Scholar
• McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 1999; 69:3-12; PMID:10418975; http://dx.doi.org/10.1016/S0960-0760(98)00144-7
   PubMed Web of Science ®Google Scholar
• Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006; 20:1405-28; PMID:16751179; http://dx.doi.org/10.1101/gad.1424806
   PubMed Web of Science ®Google Scholar
• Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996; 15:2174-83; PMID:8641283
   PubMed Web of Science ®Google Scholar
• Joel PB, Traish AM, Lannigan DA. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 1998; 273:13317-23; PMID:9582378; http://dx.doi.org/10.1074/jbc.273.21.13317
   PubMed Web of Science ®Google Scholar
• Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res 2001; 61:5985-91; PMID:11507039
   PubMed Web of Science ®Google Scholar
• Kato S. Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 2001; 8:3-9; PMID:11180760; http://dx.doi.org/10.1007/BF02967472
   PubMedGoogle Scholar
• Aronica SM, Katzenellenbogen BS. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 1993; 7:743-52; PMID:7689695
   PubMed Web of Science ®Google Scholar
• Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 1994; 8:910-8; PMID:7984152
   PubMed Web of Science ®Google Scholar
• Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK. The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Mol Biol 1994; 48:481-6; PMID:8180109; http://dx.doi.org/10.1016/0960-0760(94)90197-X
   PubMed Web of Science ®Google Scholar
• Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 1996; 137:1735-44; PMID:8612509
   PubMed Web of Science ®Google Scholar
• Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991; 254:1636-9; PMID:1749936; http://dx.doi.org/10.1126/science.1749936
   PubMed Web of Science ®Google Scholar
• Smith CL, Conneely OM, O'Malley BW. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A 1993; 90:6120-4; PMID:8327492; http://dx.doi.org/10.1073/pnas.90.13.6120
   PubMed Web of Science ®Google Scholar
• Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000; 74:311-7; PMID:11162939; http://dx.doi.org/10.1016/S0960-0760(00)00108-4
   PubMed Web of Science ®Google Scholar
• Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000; 275:5379-87; PMID:10681512; http://dx.doi.org/10.1074/jbc.275.8.5379
   PubMed Web of Science ®Google Scholar
• Liu X, Fan XL, Zhao Y, Luo GR, Li XP, Li R, Le WD. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. J Neurosci Res 2005; 81:653-65; PMID:16013043; http://dx.doi.org/10.1002/jnr.20583
   PubMed Web of Science ®Google Scholar
• Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res 1997; 25:2424-9; PMID:9171095; http://dx.doi.org/10.1093/nar/25.12.2424
   PubMed Web of Science ®Google Scholar
• Sun G, Porter W, Safe S. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Mol Endocrinol 1998; 12:882-90; PMID:9626663
   PubMed Web of Science ®Google Scholar
• Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 1994; 269:16433-42; PMID:8206951
   PubMed Web of Science ®Google Scholar
• Collins P, Webb C. Estrogen hits the surface. Nat Med 1999; 5:1130-1; PMID:10502813; http://dx.doi.org/10.1038/13453
   PubMed Web of Science ®Google Scholar
• Sylvia VL, Boyan BD, Dean DD, Schwartz Z. The membrane effects of 17beta-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J Steroid Biochem Mol Biol 2000; 73:211-24; PMID:11070350; http://dx.doi.org/10.1016/S0960-0760(00)00078-9
   PubMed Web of Science ®Google Scholar
• Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A 2002; 99:14783-8; PMID:12415108; http://dx.doi.org/10.1073/pnas.192569699
   PubMed Web of Science ®Google Scholar
• Liu S, Mauvais-Jarvis F. Rapid, nongenomic estrogen actions protect pancreatic islet survival. Islets 2009; 1:273-5; PMID:20634925; http://dx.doi.org/10.4161/isl.1.3.9781
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 2004; 69:537-42; PMID:15288766; http://dx.doi.org/10.1016/j.steroids.2004.05.009
   PubMed Web of Science ®Google Scholar
• Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999; 263:257-62; PMID:10486286; http://dx.doi.org/10.1006/bbrc.1999.1348
   PubMed Web of Science ®Google Scholar
• Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERbeta has nongenomic action in caveolae. Mol Endocrinol 2002; 16:938-46; PMID:11981029
   PubMed Web of Science ®Google Scholar
• Ripoll C, Ropero AB, Alonso-Magdalena P, Quesada I, Fuentes E, Nadal A. Rapid regulation of pancreatic alpha- and beta- cell signalling systems by estrogens. Infect Disord Drug Targets 2008; 8:61-4; PMID:18473909; http://dx.doi.org/10.2174/187152608784139668
   PubMedGoogle Scholar
• Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA, Flaws JA, Furth PA. Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 2005; 65:681-5; PMID:15705859
   PubMed Web of Science ®Google Scholar
• Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, et al. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst 2006; 98:1571-81; PMID:17077359; http://dx.doi.org/10.1093/jnci/djj415
   PubMedGoogle Scholar
• Jordan VC, O'Malley BW. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 2007; 25:5815-24; PMID:17893378; http://dx.doi.org/10.1200/JCO.2007.11.3886
   PubMed Web of Science ®Google Scholar
• Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 2000; 356:881-7; PMID:11036892; http://dx.doi.org/10.1016/S0140-6736(00)02677-5
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study G. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 2005; 97:375-84; PMID:15741574; http://dx.doi.org/10.1093/jnci/dji057
   PubMedGoogle Scholar
• de Vries SJ, van Dijk M, Bonvin AM. The HADDOCK web server for data-driven biomolecular docking. Nat Protoc 2010; 5:883-97; PMID:20431534; http://dx.doi.org/10.1038/nprot.2010.32
   PubMed Web of Science ®Google Scholar
• Corbeil CR, Williams CI, Labute P. Variability in docking success rates due to dataset preparation. J Comput Aided Mol Des 2012; 26:775-86; PMID:22566074; http://dx.doi.org/10.1007/s10822-012-9570-1
   PubMed Web of Science ®Google Scholar
• Li, Z, Joyal, JL, & Sacks, DB. Calmodulin enhances the stability of the estrogen receptor. J Biol Chem 2001; 276(20):17354-60; PMID:11278648; http://dx.doi.org/10.1074/jbc.M010238200
   PubMed Web of Science ®Google Scholar
• Krishnaraju K, Murugesan K, Vij U, Kapur BM, Farooq A. Calmodulin levels in oestrogen receptor positive and negative human breast tumours. Br J Cancer 1991; 63:346-7; PMID:2003974; http://dx.doi.org/10.1038/bjc.1991.82
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li, Z, Sacks DB, Ames JB. Structural basis for Ca2+-induced activation and dimerization of estrogen receptor alpha by calmodulin. J Biol Chem 2012; 287(12):9336-44; PMID:22275375; http://dx.doi.org/10.1074/jbc.M111.334797
   PubMed Web of Science ®Google Scholar
• Carlier, L, Byrne, C, Miclet, E, Bourgoin-Voillard, S, Nicaise, M, Tabet, JC, Jacquot, Y. Biophysical studies of the interaction between calmodulin and the R(2)(8)(7)-T(3)(1)(1) region of human estrogen receptor alpha reveals an atypical binding process. Biochem Biophys Res Commun 2012; 419(2):356-61; PMID:22342729; http://dx.doi.org/10.1016/j.bbrc.2012.02.028
   PubMed Web of Science ®Google Scholar
• Lam, H. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochemical and Biophysical Research Communications 1984; 118:27-32; PMID:6320825; http://dx.doi.org/10.1016/0006-291X(84)91062-3
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhong Q, Rhodes LV, Townley I, Bratton MR, Zhang Q, Martin EC, Elliott S, Collins-Burow BM, Burow ME and Wang G. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research 2012; 14(2): R45; PMID:24887236; http://dx.doi.org/10.1186/bcr3144
   PubMedGoogle Scholar
• Eswa, N, Webb B, Madhusudhan MS, Eramian D, Shen M, Pieper U, Sali A. Comparative Protein Structure Modeling With MODELER. In Current Protocols in Bioinformatics, AD Baxevanis AD, Stein LD, Stormo GD, and Yates JR, III, eds. Hoboken (NJ): John Wiley & Sons, Inc; 2000.
   Google Scholar
• Wriggers W, Mehler E, Pitici F, Weinstein H, Schulten K. Structure and dynamics of calmodulin in solution. Biophys J 1998; 74(4):1622-39; PMID:9545028; http://dx.doi.org/10.1016/S0006-3495(98)77876-2
   PubMed Web of Science ®Google Scholar